Company / Income Tax
Edesa Biotech, Inc. Income Tax History
FY2014-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$800
FY2021
5-year range
$0 / $36.8K
FY2017-FY2021
Trend
-
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Income Tax returned to growth in FY2021 after 2 years of decline, reaching $800.
Based on SEC 10-K filings.
$800 in FY2021 with a 5-year CAGR of -50.6%.
Remained stable around $800 over the past 3 years.
Income Tax over time
Growth rates
- 3-Year CAGR
- +0.0%
- 5-Year CAGR
- -50.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -50.6%, indicating a declining trend.
- Peak income tax was recorded in FY2017.
- Lowest income tax in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $800 | - |
| FY2020 | $0 | -100.0% |
| FY2018 | $800 | -97.8% |
| FY2017 | $36.8K | +35.3% |
| FY2016 | $27.2K | +3300.0% |
| FY2015 | $800 | +0.0% |
| FY2014 | $800 | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026